PTPRC and COVID-19: Data depicted in Figure 2A indicates that B cell percentages among CD45+ cells are markedly decreased in moderate and severe patients but are restored in convalescent individuals, in agreement with the notion that COVID-19 patients with ongoing infection show lymphopenia (22, 24).